Richard Beham
Endocrinology, Diabetes & Metabolism · Toledo, OHNPI 1568468023
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 164 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 11.4% — the pattern of someone who eats at a lot of different presentations.
Across 164 payments — averaging $13.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$253
- Lilly USA, LLC$167
- Medtronic$165
- Sanofi-aventis U.S. LLC$162
- Dexcom, Inc.$160
- Tandem Diabetes Care, Inc.$138
- plus $1K from 21 others
What the payments were for
- Food & beverage$2,20299%
- Education$141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 21 | $253 |
| Lilly USA, LLC | 17 | $167 |
| Medtronic | 13 | $165 |
| Sanofi-aventis U.S. LLC | 12 | $162 |
| Dexcom, Inc. | 13 | $160 |
| Tandem Diabetes Care, Inc. | 11 | $138 |
| Johnson & Johnson | 8 | $137 |
| AstraZeneca(2 entities) | 9 | $118 |
| Amgen(2 entities) | 8 | $105 |
| Boehringer Ingelheim | 5 | $101 |
| Abbott | 4 | $77 |
| Radius Health, Inc. | 4 | $64 |
| BD | 4 | $63 |
| AbbVie | 3 | $61 |
| Mannkind Corporation | 4 | $57 |
| Kowa Pharmaceuticals America, Inc. | 4 | $51 |
| Insulet Corporation | 4 | $51 |
| Merck | 4 | $47 |
| Shire North American Group Inc | 3 | $47 |
| Amarin Pharma, Inc. | 2 | $40 |
| Pfizer | 3 | $35 |
| Regeneron Healthcare Solutions, Inc. | 2 | $33 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $25 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| Antares Pharma, Inc. | 1 | $16 |
| Lifescan, Inc. | 1 | $16 |
| Gilead | 1 | $12 |
How this compares
$2,216 in reported general payments places this provider in the 60th percentile of 312 endocrinology, diabetes & metabolism providers in Ohio.
See all endocrinology, diabetes & metabolism providers in Ohio →
Other endocrinology, diabetes & metabolism in Toledo
- Bhaskar GundaboluToledo$471K
- Elena ChristofidesColumbus$2.3M
- Kevin PantaloneCleveland$1.2M
- John PaesWesterville$671K
- Samuel AndersonColumbus$556K
- Nelson WattsCincinnati$346K
- Baker MachhadiehHamilton$304K
- Brian BurtchMentor$264K
- Allan KennedyCleveland$245K
- Shawn PeavieCincinnati$201K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.